Commit fe1fad3a authored by Albert Hornos Vidal's avatar Albert Hornos Vidal
Browse files

content: update portal data

parent b898048e
{"entity":"COVICAT health variables model","timestamp":"2021-05-04 13:48:45.534341","links":{"self":{"href":"https:\/\/docs.google.com\/spreadsheets\/d\/e\/2PACX-1vRgouM0eO0qKvyi43S72V-x3U80vru5dOkvL9jI9lO0wYeY6A11TK5UPWlcYCCevlm7isZLzaiLfsIW\/pub?gid=416554759&single=true&output=tsv"}},"variables_counter":24,"variables":[{"variable":"H13_A2","disease":"chronic bronchitis, COPD, emphysema","possible_values":"Yes\/No"},{"variable":"H13_A3","disease":"other respiratory diseases","possible_values":"Yes\/No"},{"variable":"H13_A4","disease":"hypertension","possible_values":"Yes\/No"},{"variable":"H13_A5","disease":"heart disease","possible_values":"Yes\/No"},{"variable":"H13_A6","disease":"diabetes","possible_values":"Yes\/No"},{"variable":"H13_A7","disease":"digestive diseases","possible_values":"Yes\/No"},{"variable":"H13_A8","disease":"gynecological diseases","possible_values":"Yes\/No"},{"variable":"H13_A9","disease":"joint problems, rheumatism","possible_values":"Yes\/No"},{"variable":"H13_A10","disease":"cancer","possible_values":"Yes\/No"},{"variable":"H13_A11","disease":"anxiety \/ depression","possible_values":"Yes\/No"},{"variable":"H13_A16","disease":"other mental illnesses","possible_values":"Yes\/No"},{"variable":"H13_A12","disease":"HIV and other immunodeficiency problems","possible_values":"Yes\/No"},{"variable":"H13_A13","disease":"chronic liver disease","possible_values":"Yes\/No"},{"variable":"H13_A14","disease":"chronic kidney disease","possible_values":"Yes\/No"},{"variable":"H13_A15","disease":"autoimmune disease","possible_values":"Yes\/No"},{"variable":"H13_A17","disease":"none of the above","possible_values":"Yes\/No"},{"variable":"H02","disease":"Asthma ever","possible_values":"Yes\/No"},{"variable":"H03","disease":"Doctor Diagnosis of asthma","possible_values":"Yes\/No"},{"variable":"H04","disease":"Asthma attack last 12 months","possible_values":"Yes\/No"},{"variable":"H05","disease":"Current asthma medication","possible_values":"Yes\/No"},{"variable":"H06","disease":"Chronic bronchitis, COPD or emphysema","possible_values":"Yes\/No"},{"variable":"H07","disease":"Nasal allergy (e.g. rhinitis)","possible_values":"Yes\/No"},{"variable":"H08","disease":"Sometimes eczema or other skin allergy","possible_values":"Yes\/No"},{"variable":"H13_other","disease":"other","possible_values":"Free text"}]}
\ No newline at end of file
This diff is collapsed.
{"entity":"ISCIII's Fondo Covid Research Projects variables","timestamp":"2021-05-04 13:48:45.534799","links":{"self":{"href":"https:\/\/docs.google.com\/spreadsheets\/d\/e\/2PACX-1vRgouM0eO0qKvyi43S72V-x3U80vru5dOkvL9jI9lO0wYeY6A11TK5UPWlcYCCevlm7isZLzaiLfsIW\/pub?gid=1633544691&single=true&output=tsv"}},"variables_counter":47,"variables":{"variable group":{"group_name":"variable group","variables":{"variables":{"number_of_projects":"number of projects","percent_per_project_review":"percent per projects reviewed"}}},"Sociodemogr\u00e1ficas":{"group_name":"Sociodemogr\u00e1ficas","variables":{"Edad":{"number_of_projects":"21","percent_per_project_review":"100.00%"},"Sexo":{"number_of_projects":"21","percent_per_project_review":"100.00%"},"Peso":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Altura":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"H\u00e1bito tab\u00e1quico":{"number_of_projects":"14","percent_per_project_review":"67.00%"},"H\u00e1bito alcoh\u00f3lico":{"number_of_projects":"6","percent_per_project_review":"29.00%"}}},"Comorbilidades previas":{"group_name":"Comorbilidades previas","variables":{"HTA":{"number_of_projects":"14","percent_per_project_review":"67.00%"},"Enfermedad respiratoria":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Enfermedad renal cr\u00f3nica":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"Enfermedad hep\u00e1tica":{"number_of_projects":"10","percent_per_project_review":"48.00%"},"Obesidad":{"number_of_projects":"10","percent_per_project_review":"48.00%"},"Diabetes":{"number_of_projects":"17","percent_per_project_review":"81.00%"},"Asma":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Dislipidemia":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Enfermedad cardiovascular":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Enfermedad cerebrovascular":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Enfermedad neurol\u00f3gica":{"number_of_projects":"5","percent_per_project_review":"24.00%"},"EPOC":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"C\u00e1ncer":{"number_of_projects":"15","percent_per_project_review":"71.00%"}}},"Medicaci\u00f3n previa":{"group_name":"Medicaci\u00f3n previa","variables":{"AINES":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Estatinas":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Antibi\u00f3ticos":{"number_of_projects":"2","percent_per_project_review":"10.00%"},"ARA II":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"IECAs":{"number_of_projects":"7","percent_per_project_review":"33.00%"}}},"Fecha inicio de s\u00edntomas":{"group_name":"Fecha inicio de s\u00edntomas","variables":{"":{"number_of_projects":"10","percent_per_project_review":"48.00%"}}},"Fecha ingreso en el hospital":{"group_name":"Fecha ingreso en el hospital","variables":{"":{"number_of_projects":"12","percent_per_project_review":"57.00%"}}},"S\u00edntomas previos al ingreso":{"group_name":"S\u00edntomas previos al ingreso","variables":{"Fiebre":{"number_of_projects":"13","percent_per_project_review":"62.00%"},"Tos":{"number_of_projects":"13","percent_per_project_review":"62.00%"},"Disnea":{"number_of_projects":"10","percent_per_project_review":"48.00%"},"Anosmia":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Ageusia":{"number_of_projects":"8","percent_per_project_review":"38.00%"},"Cefalea":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"Diarrea":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"Mialgias":{"number_of_projects":"10","percent_per_project_review":"48.00%"}}},"Tratamiento durante hospitalizaci\u00f3n":{"group_name":"Tratamiento durante hospitalizaci\u00f3n","variables":{"Hidroxicloroquina":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Antivirales":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Antibi\u00f3ticos":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Corticoides":{"number_of_projects":"4","percent_per_project_review":"19.00%"},"Ox\u00edgeno convencional":{"number_of_projects":"8","percent_per_project_review":"38.00%"},"Oxigeno alto flujo":{"number_of_projects":"9","percent_per_project_review":"43.00%"}}},"Procedimientos":{"group_name":"Procedimientos","variables":{"Ventilaci\u00f3n mec\u00e1nica no invasiva":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Ventilaci\u00f3n mec\u00e1nica invasiva":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"ECMO":{"number_of_projects":"5","percent_per_project_review":"24.00%"}}},"Fecha de ingreso en UCI":{"group_name":"Fecha de ingreso en UCI","variables":{"":{"number_of_projects":"9","percent_per_project_review":"43.00%"}}},"Fallecimiento":{"group_name":"Fallecimiento","variables":{"":{"number_of_projects":"14","percent_per_project_review":"67.00%"}}},"Fecha de fallecimiento":{"group_name":"Fecha de fallecimiento","variables":{"":{"number_of_projects":"13","percent_per_project_review":"62.00%"}}}}}
\ No newline at end of file
This diff is collapsed.
This diff is collapsed.
{
"entity": "Spanish working spaces on COVID-19",
"timestamp": "2021-03-09 13:32:00.000000",
"links": {
"origin": {
"href": ""
}
},
"working_spaces_counter": 2,
"working_spaces": [
{
"title": "COVID-19 Virtual Research Environment",
"acronym": "VRE",
"type": "working space",
"description": "<p>Virtual research environments (VREs) are online computational workbenches providing researchers access to relevant datasets, analysis pipelines and visualizers in an integrated manner.</p><p>Using <a href=\"https://github.com/inab/openVRE\">openVRE</a> framework, we are building a cloud-based VRE integrating data repositories and analyses relevant for COVID-19 research. This dedicated instance will include access to the <a href=\"https://ega-archive.org\">European Genome-Phenome Archive</a>, <a href=\"https://www.eurobioimaging.eu\">EuroBioImaging</a>, as well as to the ISCIII COVID-19 registry. Importantly, users willinging to use access controlled data should follow the established guidelines for each of the repositories. Other public resources, e.g. <a href=\"https://www.ebi.ac.uk/ena/browser/home\">European Nucleotide Archive</a>, will also be accessible from the platform. The VRE will be equipped with different analysis toolkits. If you are interested in aggregating your own analysis or data service, please <a href=\"mailto:{{ .Site.Params.emails.dataportalSpain }}\">contact us</a>.</p>",
"developer": "",
"developer_link": "",
"item_link": "",
"img": {
"alt": "VRE logo",
"src": "vre-logo.svg"
}
},
{
"title": "COVID-19 Galaxy Spain",
"acronym": "",
"type": "working space",
"description": "<p>UseGalaxy.es is the Spanish Galaxy Instance powered by the computational cloud infrastructure associated with the <a href=\"https://www.bsc.es/es/marenostrum/star-life\">StarLife</a> project. The instance is maintained by the INB/ELIXIR-ES teams at the Barcelona Supercomputing Center (BSC) in close collaboration with European partners from the UseGalaxy.eu network and ELIXIR, the European Life Science Infrastructure for Biological Information. The instance contains specific tools and workflows to analyse COVID-19 data, COVID-19 genomics and COVID-19 cheminformatics.</p><p><a href=\"http://galaxyproject.org\">Galaxy</a> is an open, web-based platform for accessible, reproducible, and transparent computational research. <a href=\"https://galaxyproject.github.io\">The Galaxy Project</a> is developed and supported by a broad international research community.</p>",
"developer": "",
"developer_link": "",
"href": "https://covid19.usegalaxy.es",
"img": {
"alt": "Galaxy Europe logo",
"src": "usegalaxy-eu-logo.svg"
}
}
]
}
\ No newline at end of file
{"entity":"Spanish Working spaces on COVID-19","timestamp":"2021-05-04 13:48:45.439776","links":{"origin":{"href":"https:\/\/docs.google.com\/spreadsheets\/d\/e\/2PACX-1vRgouM0eO0qKvyi43S72V-x3U80vru5dOkvL9jI9lO0wYeY6A11TK5UPWlcYCCevlm7isZLzaiLfsIW\/pub?gid=1958727862&single=true&output=tsv"}},"working_spaces_counter":2,"working_spaces":[{"name":"COVID-19 Virtual Research Environment","acronym":" COVID-19 VRE","type":"working space","bio_type":"","description":"<p>Virtual research environments (VREs) are online computational workbenches providing researchers access to relevant datasets, analysis pipelines and visualizers in an integrated manner.<\/p><p>Using <a href=\\\"https:\/\/github.com\/inab\/openVRE\\\">openVRE<\/a> framework, we are building a cloud-based VRE integrating data repositories and analyses relevant for COVID-19 research. This dedicated instance will include access to the <a href=\\\"https:\/\/ega-archive.org\\\">European Genome-Phenome Archive<\/a>, <a href=\\\"https:\/\/www.eurobioimaging.eu\\\">EuroBioImaging<\/a>, as well as to the ISCIII COVID-19 registry. Importantly, users willinging to use access controlled data should follow the established guidelines for each of the repositories. Other public resources, e.g. <a href=\\\"https:\/\/www.ebi.ac.uk\/ena\/browser\/home\\\">European Nucleotide Archive<\/a>, will also be accessible from the platform. The VRE will be equipped with different analysis toolkits. If you are interested in aggregating your own analysis or data service, please <a href=\\\"mailto:{{ .Site.Params.emails.dataportalSpain }}\\\">contact us<\/a>.<\/p>","developer":"INB Computational and Coordination Unit, Barcelona Supercomputing Center (BSC)","developer_link":"https:\/\/www.bsc.es\/discover-bsc\/organisation\/scientific-structure\/spanish-national-bioinformatics-institute-inbelixir","item_link":"","images":[{"alt":"VRE logo","file":"vre-logo.svg"}]},{"name":"COVID-19 Galaxy Spain","acronym":"","type":"working space","bio_type":"","description":"<p>UseGalaxy.es is the Spanish Galaxy Instance powered by the computational cloud infrastructure associated with the <a href=\\\"https:\/\/www.bsc.es\/es\/marenostrum\/star-life\\\">StarLife<\/a> project. The instance is maintained by the INB\/ELIXIR-ES teams at the Barcelona Supercomputing Center (BSC) in close collaboration with European partners from the UseGalaxy.eu network and ELIXIR, the European Life Science Infrastructure for Biological Information. The instance contains specific tools and workflows to analyse COVID-19 data, COVID-19 genomics and COVID-19 cheminformatics.<\/p><p><a href=\\\"http:\/\/galaxyproject.org\\\">Galaxy<\/a> is an open, web-based platform for accessible, reproducible, and transparent computational research. <a href=\\\"https:\/\/galaxyproject.github.io\\\">The Galaxy Project<\/a> is developed and supported by a broad international research community.<\/p>","developer":"INB Computational and Coordination Unit, Barcelona Supercomputing Center (BSC)","developer_link":"https:\/\/www.bsc.es\/discover-bsc\/organisation\/scientific-structure\/spanish-national-bioinformatics-institute-inbelixir","item_link":"https:\/\/covid19.usegalaxy.es","images":[{"alt":"Galaxy Europe logo","file":"usegalaxy-eu-logo.svg"}]}]}
\ No newline at end of file
{"entity":"SARS-CoV-2 host sequences from Spain powered by ENA","timestamp":"2021-03-03 22:29:17.256300","links":{"self":{"href":"https:\/\/docs.google.com\/spreadsheets\/d\/e\/2PACX-1vRgouM0eO0qKvyi43S72V-x3U80vru5dOkvL9jI9lO0wYeY6A11TK5UPWlcYCCevlm7isZLzaiLfsIW\/pub?gid=1484477925&single=true&output=tsv"},"origin":{"href":"https:\/\/www.covid19dataportal.org\/host-sequences?db=other-experiment&size=15&facets=country:Spain&requestFrom=searchBox#search-content"}},"host_sequences_counter":18,"host_sequences":[{"accession_id":"SRX8264272","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264274","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264275","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264278","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264280","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264282","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264283","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264285","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264286","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264288","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264271","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264273","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264276","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264277","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264279","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264281","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264284","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: MILD case","country":"Spain","region":"Catalunya"},{"accession_id":"SRX8264287","description":"Illumina MiSeq sequencing; SARS-CoV-2 whole SPIKE-Seq: SEVERE case","country":"Spain","region":"Catalunya"}]}
\ No newline at end of file
{"entity":"ISCIII's Fondo Covid Research Projects variables","timestamp":"2021-03-08 14:43:29.022137","links":{"self":{"href":"https:\/\/docs.google.com\/spreadsheets\/d\/e\/2PACX-1vRgouM0eO0qKvyi43S72V-x3U80vru5dOkvL9jI9lO0wYeY6A11TK5UPWlcYCCevlm7isZLzaiLfsIW\/pub?gid=1633544691&single=true&output=tsv"}},"variables_counter":46,"health_isciii_variables":{"Sociodemogr\u00e1ficas":{"group_name":"Sociodemogr\u00e1ficas","variables":{"Edad":{"number_of_projects":"21","percent_per_project_review":"100.00%"},"Sexo":{"number_of_projects":"21","percent_per_project_review":"100.00%"},"Peso":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Altura":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"H\u00e1bito tab\u00e1quico":{"number_of_projects":"14","percent_per_project_review":"67.00%"},"H\u00e1bito alcoh\u00f3lico":{"number_of_projects":"6","percent_per_project_review":"29.00%"}}},"Comorbilidades previas":{"group_name":"Comorbilidades previas","variables":{"HTA":{"number_of_projects":"14","percent_per_project_review":"67.00%"},"Enfermedad respiratoria":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Enfermedad renal cr\u00f3nica":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"Enfermedad hep\u00e1tica":{"number_of_projects":"10","percent_per_project_review":"48.00%"},"Obesidad":{"number_of_projects":"10","percent_per_project_review":"48.00%"},"Diabetes":{"number_of_projects":"17","percent_per_project_review":"81.00%"},"Asma":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Dislipidemia":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Enfermedad cardiovascular":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Enfermedad cerebrovascular":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Enfermedad neurol\u00f3gica":{"number_of_projects":"5","percent_per_project_review":"24.00%"},"EPOC":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"C\u00e1ncer":{"number_of_projects":"15","percent_per_project_review":"71.00%"}}},"Medicaci\u00f3n previa":{"group_name":"Medicaci\u00f3n previa","variables":{"AINES":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Estatinas":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"Antibi\u00f3ticos":{"number_of_projects":"2","percent_per_project_review":"10.00%"},"ARA II":{"number_of_projects":"6","percent_per_project_review":"29.00%"},"IECAs":{"number_of_projects":"7","percent_per_project_review":"33.00%"}}},"Fecha inicio de s\u00edntomas":{"group_name":"Fecha inicio de s\u00edntomas","variables":{"":{"number_of_projects":"10","percent_per_project_review":"48.00%"}}},"Fecha ingreso en el hospital":{"group_name":"Fecha ingreso en el hospital","variables":{"":{"number_of_projects":"12","percent_per_project_review":"57.00%"}}},"S\u00edntomas previos al ingreso":{"group_name":"S\u00edntomas previos al ingreso","variables":{"Fiebre":{"number_of_projects":"13","percent_per_project_review":"62.00%"},"Tos":{"number_of_projects":"13","percent_per_project_review":"62.00%"},"Disnea":{"number_of_projects":"10","percent_per_project_review":"48.00%"},"Anosmia":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Ageusia":{"number_of_projects":"8","percent_per_project_review":"38.00%"},"Cefalea":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"Diarrea":{"number_of_projects":"11","percent_per_project_review":"52.00%"},"Mialgias":{"number_of_projects":"10","percent_per_project_review":"48.00%"}}},"Tratamiento durante hospitalizaci\u00f3n":{"group_name":"Tratamiento durante hospitalizaci\u00f3n","variables":{"Hidroxicloroquina":{"number_of_projects":"7","percent_per_project_review":"33.00%"},"Antivirales":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Antibi\u00f3ticos":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Corticoides":{"number_of_projects":"4","percent_per_project_review":"19.00%"},"Ox\u00edgeno convencional":{"number_of_projects":"8","percent_per_project_review":"38.00%"},"Oxigeno alto flujo":{"number_of_projects":"9","percent_per_project_review":"43.00%"}}},"Procedimientos":{"group_name":"Procedimientos","variables":{"Ventilaci\u00f3n mec\u00e1nica no invasiva":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"Ventilaci\u00f3n mec\u00e1nica invasiva":{"number_of_projects":"9","percent_per_project_review":"43.00%"},"ECMO":{"number_of_projects":"5","percent_per_project_review":"24.00%"}}},"Fecha de ingreso en UCI":{"group_name":"Fecha de ingreso en UCI","variables":{"":{"number_of_projects":"9","percent_per_project_review":"43.00%"}}},"Fallecimiento":{"group_name":"Fallecimiento","variables":{"":{"number_of_projects":"14","percent_per_project_review":"67.00%"}}},"Fecha de fallecimiento":{"group_name":"Fecha de fallecimiento","variables":{"":{"number_of_projects":"13","percent_per_project_review":"62.00%"}}}}}
\ No newline at end of file
{
"entity": "health_covicat_variables",
"timestamp": "2021-02-10 17:30:00",
"links": {
"self": {
"href": "https://inb-elixir.es/"
},
"origin": {
"href": ""
}
},
"project_count": 24,
"health_covicat_variables": [
{
"variable": "H13_A2",
"disease": "chronic bronchitis, COPD, emphysema",
"possible_values": "Yes/No"
},
{
"variable": "H13_A3",
"disease": "other respiratory diseases",
"possible_values": "Yes/No"
},
{
"variable": "H13_A4",
"disease": "hypertension",
"possible_values": "Yes/No"
},
{
"variable": "H13_A5",
"disease": "heart disease",
"possible_values": "Yes/No"
},
{
"variable": "H13_A6",
"disease": "diabetes",
"possible_values": "Yes/No"
},
{
"variable": "H13_A7",
"disease": "digestive diseases",
"possible_values": "Yes/No"
},
{
"variable": "H13_A8",
"disease": "gynecological diseases",
"possible_values": "Yes/No"
},
{
"variable": "H13_A9",
"disease": "joint problems, rheumatism",
"possible_values": "Yes/No"
},
{
"variable": "H13_A10",
"disease": "cancer",
"possible_values": "Yes/No"
},
{
"variable": "H13_A11",
"disease": "anxiety / depression",
"possible_values": "Yes/No"
},
{
"variable": "H13_A16",
"disease": "other mental illnesses",
"possible_values": "Yes/No"
},
{
"variable": "H13_A12",
"disease": "HIV and other immunodeficiency problems",
"possible_values": "Yes/No"
},
{
"variable": "H13_A13",
"disease": "chronic liver disease",
"possible_values": "Yes/No"
},
{
"variable": "H13_A14",
"disease": "chronic kidney disease",
"possible_values": "Yes/No"
},
{
"variable": "H13_A15",
"disease": "autoimmune disease",
"possible_values": "Yes/No"
},
{
"variable": "H13_A17",
"disease": "none of the above",
"possible_values": "Yes/No"
},
{
"variable": "H02",
"disease": "Asthma ever",
"possible_values": "Yes/No"
},
{
"variable": "H03",
"disease": "Doctor Diagnosis of asthma",
"possible_values": "Yes/No"
},
{
"variable": "H04",
"disease": "Asthma attack last 12 months",
"possible_values": "Yes/No"
},
{
"variable": "H05",
"disease": "Current asthma medication",
"possible_values": "Yes/No"
},
{
"variable": "H06",
"disease": "Chronic bronchitis, COPD or emphysema",
"possible_values": "Yes/No"
},
{
"variable": "H07",
"disease": "Nasal allergy (e.g. rhinitis)",
"possible_values": "Yes/No"
},
{
"variable": "H08",
"disease": "Sometimes eczema or other skin allergy",
"possible_values": "Yes/No"
},
{
"variable": "H13_other",
"disease": "other",
"possible_values": "Free text"
}
]
}
\ No newline at end of file
This diff is collapsed.
{
"entity": "health_isaric_variables",
"timestamp": "2021-02-10 16:03:42",
"links": {
"self": {
"href": "https://inb-elixir.es/"
},
"origin": {
"href": "https://doi.org/10.1016/j.jbi.2021.103697"
}
},
"project_count": 58,
"health_isaric_variables": [
{
"observation_type": "Clinical",
"concept": "Height",
"data_type": "PQ",
"values_unit": "cm",
"terminology_type": "SNOMED CT",
"term": "50373000 |Body height measure (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Weight",
"data_type": "PQ",
"values_unit": "kg",
"terminology_type": "SNOMED CT",
"term": "27113001 |Body weight (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Temperature",
"data_type": "PQ",
"values_unit": "ºC",
"terminology_type": "SNOMED CT",
"term": "386725007 |Body temperature (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Heart rate",
"data_type": "PQ",
"values_unit": "lat/min",
"terminology_type": "SNOMED CT",
"term": "364075005 |Heart rate (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Respiratory rate",
"data_type": "PQ",
"values_unit": "resp/min",
"terminology_type": "SNOMED CT",
"term": "86290005 |Respiratory rate (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Systolic blood pressure",
"data_type": "PQ",
"values_unit": "mmHg",
"terminology_type": "SNOMED CT",
"term": "271649006 |Systolic blood pressure (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Diastolic blood pressure",
"data_type": "PQ",
"values_unit": "mmHg",
"terminology_type": "SNOMED CT",
"term": "271650006 |Diastolic blood pressure (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Oxygen saturation",
"data_type": "PQ",
"values_unit": "%",
"terminology_type": "SNOMED CT",
"term": "103228002 |Hemoglobin saturation with oxygen (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Oxygen concentration",
"data_type": "PQ",
"values_unit": "%",
"terminology_type": "SNOMED CT",
"term": "425608004 |Delivered oxygen concentration (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Oxygen flow rate",
"data_type": "PQ",
"values_unit": "L/min",
"terminology_type": "SNOMED CT",
"term": "427081008 |Delivered oxygen flow rate (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Mean blood pressure",
"data_type": "PQ",
"values_unit": "mmHg",
"terminology_type": "SNOMED CT",
"term": "6797001 |Mean blood pressure (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Defecation",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "162098000 |Frequency of defecation (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Urination",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "364198000 |Frequency of urination (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Vomit",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "63361000122100 |Frequency of vomits (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Smoking habit",
"data_type": "CV",
"values_unit": "Non-smoker Ex-smoker Smoker",
"terminology_type": "SNOMED CT",
"term": "266918002 |Tobacco smoking consumption (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Tobacco exposure",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "782516008 |Number of calculated pack years for cumulative lifetime tobacco exposure (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Date started smoking",
"data_type": "DATE",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "63371000122105 |Date started smoking (observable entity)",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Date ceased smoking",
"data_type": "DATE",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "160625004 |Date ceased smoking (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "Glasgow Coma score",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "248241002 |Glasgow coma score (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "qSOFA score",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "63451000122107 |qSOFA score (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "SOFA score",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "63441000122105 |SOFA score (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Clinical",
"concept": "NEWS score",
"data_type": "INTEGER",
"values_unit": "",
"terminology_type": "SNOMED CT",
"term": "63441000122102 |NEWS score (observable entity)|",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "SARS-COV-2",
"data_type": "CV",
"values_unit": "Positive/ Negative/ Equivocal",
"terminology_type": "LOINC",
"term": "94315-9 |SARS coronavirus 2 E gene [Presence] in Unspecified specimen by NAA with probe detection",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Hemoglobin",
"data_type": "PQ",
"values_unit": "g/dL",
"terminology_type": "LOINC",
"term": "718-7 Hemoglobin [Mass/volume] in Blood",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Leukocytes",
"data_type": "PQ",
"values_unit": "x1000/μL",
"terminology_type": "LOINC",
"term": "6690-2 Leukocytes [#/volume] in Blood by Automated count",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Lymphocytes",
"data_type": "PQ",
"values_unit": "x1000/μL",
"terminology_type": "LOINC",
"term": "731-0 Lymphocytes [#/volume] in Blood by Automated count",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Platelets",
"data_type": "PQ",
"values_unit": "x1000/μL",
"terminology_type": "LOINC",
"term": "777-3 Platelets [#/volume] in Blood by Automated count",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Neutrophils",
"data_type": "PQ",
"values_unit": "x1000/μL",
"terminology_type": "LOINC",
"term": "751-8 Neutrophils [#/volume] in Blood by Automated count",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Eosinophils",
"data_type": "PQ",
"values_unit": "x1000/μL",
"terminology_type": "LOINC",
"term": "711-2 Eosinophils [#/volume] in Blood by Automated count",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Basophils",
"data_type": "PQ",
"values_unit": "x1000/μL",
"terminology_type": "LOINC",
"term": "704-7 Basophils [#/volume] in Blood by Automated count",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Hematocrit",
"data_type": "PQ",
"values_unit": "%",
"terminology_type": "LOINC",
"term": "4544-3 Hematocrit [Volume Fraction] of Blood by Automated count",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "aPTT",
"data_type": "PQ",
"values_unit": "Sec",
"terminology_type": "LOINC",
"term": "3173-2 aPTT in Blood by Coagulation assay",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Prothrombin time",
"data_type": "PQ",
"values_unit": "Sec",
"terminology_type": "LOINC",
"term": "5902-2 Prothrombin time (PT)",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "INR",
"data_type": "PQ",
"values_unit": "{INR}",
"terminology_type": "LOINC",
"term": "6301-6 INR in Platelet poor plasma by Coagulation assay",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Albumin",
"data_type": "PQ",
"values_unit": "g/dL",
"terminology_type": "LOINC",
"term": "1751-7 Albumin [Mass/volume] in Serum or Plasma",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "ALT/SGPT",
"data_type": "PQ",
"values_unit": "U/L",
"terminology_type": "LOINC",
"term": "1742-6 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "Bilirubin",
"data_type": "PQ",
"values_unit": "mg/dL",
"terminology_type": "LOINC",
"term": "1975-2 Bilirubin.total [Mass/volume] in Serum or Plasma",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},
{
"observation_type": "Laboratory related",
"concept": "AST/SGOT",
"data_type": "PQ",
"values_unit": "U/L",
"terminology_type": "LOINC",
"term": "1920-8 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
"source": "https://doi.org/10.1016/j.jbi.2021.103697"
},